Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Mackey

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Can quantifying hormone receptor levels guide the choice of adjuvant endocrine therapy for breast cancer?John R Mackey
Clinical Breast Cancer|February 14, 2008
Delayed resolution of jaundice in the arm of a patient with impaired lymphatic drainage: a case reportRoger Y Tsang, John R Mackey
International Journal of Cancer|January 13, 2005
Skeletal health in postmenopausal survivors of early breast cancerJohn R Mackey, Anil A Joy
Cancers|November 28, 2013
Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment DecisionsJennifer L Spratlin, John R Mackey
Cancer Management and Research|June 7, 2014
Presentation and management of docetaxel-related adverse effects in patients with breast cancerMaria Y Ho, John R Mackey
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|October 24, 2002
Large-volume air embolism as a complication of augmented computed tomography: case reportJennifer Sheasgreen, Tim Terry, John R Mackey
Pharmaceutical Statistics|April 7, 2025
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk-Benefit AnalysisUtkarsh Chauhan, Daylen Mackey, John R Mackey
Translational Oncology|December 17, 2020
Proposal for 'segmented peer review' of multidisciplinary papersDeepak Dinakaran, Matthew Anaka, John R Mackey
The Lancet. Oncology|July 27, 2002
Nucleoside analogues and nucleobases in cancer treatmentCarlos M Galmarini, John R Mackey, Charles Dumontet
Future Oncology (London, England)|July 14, 2010
Ramucirumab (IMC-1121B): a novel attack on angiogenesisJennifer L Spratlin, Karen E Mulder, John R Mackey
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Can quantifying hormone receptor levels guide the choice of adjuvant endocrine therapy for breast cancer?John R Mackey
Clinical Breast Cancer|February 14, 2008
Delayed resolution of jaundice in the arm of a patient with impaired lymphatic drainage: a case reportRoger Y Tsang, John R Mackey
International Journal of Cancer|January 13, 2005
Skeletal health in postmenopausal survivors of early breast cancerJohn R Mackey, Anil A Joy
Cancers|November 28, 2013
Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment DecisionsJennifer L Spratlin, John R Mackey
Cancer Management and Research|June 7, 2014
Presentation and management of docetaxel-related adverse effects in patients with breast cancerMaria Y Ho, John R Mackey
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|October 24, 2002
Large-volume air embolism as a complication of augmented computed tomography: case reportJennifer Sheasgreen, Tim Terry, John R Mackey
Pharmaceutical Statistics|April 7, 2025
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk-Benefit AnalysisUtkarsh Chauhan, Daylen Mackey, John R Mackey
Translational Oncology|December 17, 2020
Proposal for 'segmented peer review' of multidisciplinary papersDeepak Dinakaran, Matthew Anaka, John R Mackey
The Lancet. Oncology|July 27, 2002
Nucleoside analogues and nucleobases in cancer treatmentCarlos M Galmarini, John R Mackey, Charles Dumontet
Future Oncology (London, England)|July 14, 2010
Ramucirumab (IMC-1121B): a novel attack on angiogenesisJennifer L Spratlin, Karen E Mulder, John R Mackey
Pageof 23